Searching News Database: Axsome Therapeutics
HSMN NewsFeed - 28 Mar 2022
Jazz Pharmaceuticals Announces Agreement to Divest Sunosi(R) (solriamfetol) to Axsome Therapeutics
Jazz Pharmaceuticals Announces Agreement to Divest Sunosi(R) (solriamfetol) to Axsome Therapeutics
HSMN NewsFeed - 7 Nov 2019
Neurana Pharmaceuticals Appoints Randall Kaye, M.D., Chief Medical Officer
Neurana Pharmaceuticals Appoints Randall Kaye, M.D., Chief Medical Officer